In vitro activity of sitafloxacin against Burkholderia pseudomallei

被引：1
|
作者：
Thamlikitkul, Visanu [1 ]
Trakulsomboon, Suwanna [1 ]
机构：
[1] Mahidol Univ, Siriraj Hosp, Fac Med, Div Infect Dis & Trop Med,Dept Med, Bangkok 10700, Thailand
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2011年 / 38卷 / 04期
关键词：
RESISTANCE;
D O I：
10.1016/j.ijantimicag.2011.06.004
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：364 / 364
页数：1
相关论文
共 50 条
  • [21] Demonstrating the Protective Efficacy of the Novel Fluoroquinolone Finafloxacin against an Inhalational Exposure to Burkholderia pseudomallei
    Barnes, Kay B.
    Hamblin, Karleigh A.
    Richards, Mark I.
    Laws, Thomas R.
    Vente, Andreas
    Atkins, Helen S.
    Harding, Sarah V.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (07)
  • [22] Expression of virulence and antimicrobial related proteins in Burkholderia mallei and Burkholderia pseudomallei
    Paauw, Armand
    Scholz, Holger C. C.
    Mars-Groenendijk, Roos H. H.
    Dekker, Lennard J. M.
    Luider, Theo M. M.
    van Leeuwen, Hans C. C.
    PLOS NEGLECTED TROPICAL DISEASES, 2023, 17 (01):
  • [23] Knockout and pullout recombineering for naturally transformable Burkholderia thailandensis and Burkholderia pseudomallei
    Kang, Yun
    Norris, Michael H.
    Wilcox, Bruce A.
    Tuanyok, Apichai
    Keim, Paul S.
    Hoang, Tung T.
    NATURE PROTOCOLS, 2011, 6 (08) : 1085 - 1104
  • [24] In vitro susceptibility of Burkholderia pseudomallei isolates from Thai patients to ceftolozane/tazobactam and ceftazidime/avibactam
    Sribenjalux, Wantin
    Wonglakorn, Lumyai
    Meesing, Atibordee
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2022, 28 : 8 - 11
  • [25] Experimental Phage Therapy for Burkholderia pseudomallei Infection
    Guang-Han, Ong
    Leang-Chung, Choh
    Vellasamy, Kumutha Malar
    Mariappan, Vanitha
    Li-Yen, Chang
    Vadivelu, Jamuna
    PLOS ONE, 2016, 11 (07):
  • [26] Exploring Cefiderocol Resistance Mechanisms in Burkholderia pseudomallei
    Hall, Carina M. M.
    Somprasong, Nawarat
    Hagen, Johannah P. P.
    Nottingham, Roxanne
    Sahl, Jason W. W.
    Webb, Jessica R. R.
    Mayo, Mark
    Currie, Bart J. J.
    Podin, Yuwana
    Wagner, David M. M.
    Keim, Paul
    Schweizer, Herbert P. P.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (06)
  • [27] Polysaccharide Specific Monoclonal Antibodies Provide Passive Protection against Intranasal Challenge with Burkholderia pseudomallei
    AuCoin, David P.
    Reed, Dana E.
    Marlenee, Nicole L.
    Bowen, Richard A.
    Thorkildson, Peter
    Judy, Barbara M.
    Torres, Alfredo G.
    Kozel, Thomas R.
    PLOS ONE, 2012, 7 (04):
  • [28] Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against Burkholderia cepacia complex species
    Annelien Everaert
    Tom Coenye
    Antimicrobial Resistance & Infection Control, 5
  • [29] Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against Burkholderia cepacia complex species
    Everaert, Annelien
    Coenye, Tom
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2016, 5
  • [30] In Vitro Antibacterial Activity and In Vivo Efficacy of Sulbactam-Durlobactam against Pathogenic Burkholderia Species
    Papp-Wallace, Krisztina M.
    Shapiro, Adam B.
    Becka, Scott A.
    Zeiser, Elise T.
    LiPuma, John J.
    Lane, Douglas J.
    Panchal, Rekha G.
    Mueller, John P.
    O'Donnell, John P.
    Miller, Alita A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (03)
12345